Depression is common and linked with early death in patients with blood cancers

In a Psycho-Oncology study of patients newly diagnosed with lymphoma or multiple myeloma, one-third of participants reported depressive symptoms around the time of diagnosis, and depressive symptoms were linked with shorter survival. Shorter survival was observed in both patients who remained depressed and patients who recovered from depressive symptoms.

The study included 255 patients, of whom 83 had depression. Over a median follow-up of approximately 3.5 years, 61 patients died. These included 30 patients in the “never depression” group, 6 patients in the “new-onset” group, 16 patients in the “remission” group, and 9 patients in the “persistent” group. These groups were based on depressive symptoms assessed before starting cancer treatment and one month later.

Source: Read Full Article

Related posts:
  1. Patients with both schizophrenia and epilepsy die alarmingly early
  2. Vitamin D levels in the blood linked to cardiorespiratory fitness
  3. Shared genetic marker offers new promise in targeting specific ovarian and lung cancers
  4. Web tool aims to better inform and refine need for treatment in early prostate cancer
  5. Finally, another effective drug for kids and teens with type 2 diabetes